debate: should consolidation and minimal residual disease testing be used? - no
Published 9 years ago • 103 plays • Length 9:07Download video MP4
Download video MP3
Similar videos
-
9:11
debate: should consolidation and minimal residual disease testing be used? - yes
-
21:09
minimal residual disease (mrd) in cll: is it clinically relevant?
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
10:19
myeloma debate: is mrd ready for prime time? - no
-
16:26
debate: is cr and mrd negativity still required in the era of novel agents? - no
-
1:48:52
webinar: cms's coverage decision: it's not just about alzheimer's disease
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
40:58
dis:united nations working towards effective multilateralism
-
21:18
myeloma debate: is mrd ready for prime time? - yes
-
19:41
multiple myeloma: minimal residual disease
-
10:50
debate: use of mrd measurements in myeloma - not yet ready for prime time in standard care
-
14:14
debate: is mrd the new primary goal for multiple myeloma treatment? - no
-
3:07
minimal residual disease (mrd)
-
13:07
debate: mrd, ready for primetime? - no
-
12:26
debate: mrd, ready for primetime? - yes
-
22:56
measurable residual disease (mrd) in aml and all
-
1:19
mrd testing should be more widely available
-
4:20
an overview of minimal residual disease testing
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
3:44
what is mrd, or minimal residual disease?
-
27:12
minimal residual disease: overview, flow cytometry, cog experience - stephen hunger, md
-
18:50
mrd detection, single cell rna seq., cell free dna, etc: does it impact treatment?